Kenneth Carl Anderson - Oct 3, 2022 Form 4 Insider Report for C4 Therapeutics, Inc. (CCCC)

Role
Director
Signature
/s/ Jolie M. Siegel, Attorney-in-Fact
Stock symbol
CCCC
Transactions as of
Oct 3, 2022
Transactions value $
$12,773
Form type
4
Date filed
10/4/2022, 06:05 PM
Previous filing
Jul 18, 2022
Next filing
Jan 4, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CCCC Common Stock Options Exercise $563 +267 +0.29% $2.11 91.3K Oct 3, 2022 Direct
transaction CCCC Common Stock Options Exercise $2.22K +445 +0.49% $4.98 91.7K Oct 3, 2022 Direct
transaction CCCC Common Stock Award $9.99K +1.15K +1.25% $8.69 92.8K Oct 3, 2022 Direct F1, F2
holding CCCC Common Stock 47.3K Oct 3, 2022 By Spouse
holding CCCC Common Stock 61.3K Oct 3, 2022 By Kenneth C. Anderson 2016 Grantor Retained Annuity Trust F3
holding CCCC Common Stock 61.3K Oct 3, 2022 By Cynthia E. Anderson 2016 Grantor Retained Annuity Trust F4
holding CCCC Common Stock 16.9K Oct 3, 2022 By Kenneth C. Anderson 2015 Irrevocable Trust F5
holding CCCC Common Stock 16.9K Oct 3, 2022 By Cynthia E. Anderson 2015 Irrevocable Trust F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CCCC Stock Option (Right to Buy) Options Exercise $0 -267 -16.67% $0.00 1.34K Oct 3, 2022 Common Stock 267 $2.11 Direct F7
transaction CCCC Stock Option (Right to Buy) Options Exercise $0 -445 -25.01% $0.00 1.33K Oct 3, 2022 Common Stock 445 $4.98 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were issued in accordance with the Issuer's Non-Employee Director Compensation Policy, pursuant to which the Reporting Person elected to receive shares of the Issuer's common stock in lieu of cash compensation for services as a non-employee director of the Issuer.
F2 The price reported in Column 4 is based upon the closing market price of the Issuer's common stock on October 3, 2022.
F3 Shares held by the Kenneth C. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F4 Shares held by the Cynthia E. Anderson 2016 Grantor Retained Annuity Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F5 Shares held by the Kenneth C. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F6 Shares held by the Cynthia E. Anderson 2015 Irrevocable Trust. The Reporting Person disclaims beneficial ownership of these shares except to the extent of his pecuniary interest therein.
F7 12.5% of the shares underlying this option vested and became exercisable on December 31, 2016, with the remainder vesting in 28 equal quarterly installments thereafter.
F8 The shares underlying this option vest and become exercisable in 12 equal quarterly installments, with the first installment vested on October 1, 2020.